SEI Medical PCL
SET:SEI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its 3-Year Average (6.2), the stock would be worth ฿2.54 (25% upside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 5 | ฿2.04 |
0%
|
| 3-Year Average | 6.2 | ฿2.54 |
+25%
|
| 5-Year Average | 6.2 | ฿2.54 |
+25%
|
| Industry Average | 17.1 | ฿6.94 |
+240%
|
| Country Average | 13.4 | ฿5.47 |
+168%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| TH |
S
|
SEI Medical PCL
SET:SEI
|
346.8m THB | 5 | 5.5 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
100.3B USD | 12.5 | 23.1 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
60.7B USD | 20.2 | 37.4 | |
| US |
|
Cencora Inc
NYSE:COR
|
59.9B USD | 20 | 36.9 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
45.5B USD | 6.7 | 27.4 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
32.1B AUD | 40.8 | 35.4 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
62.8B CNY | 21.6 | 11.1 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
58.8B CNY | 136.2 | 20.6 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.6B USD | 9 | 21.7 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | -236.8 | 89.6 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
58.6B HKD | -35.6 | 7.2 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 8.8 |
| Median | 13.4 |
| 70th Percentile | 20 |
| Max | 1 747 |
Other Multiples
SEI Medical PCL
Glance View
SEI Medical PCL is a TH-based company operating in Health Care Providers & Services industry. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2024-09-24. SEI Medical Public Company Limited is a Thailand-based distributor and service provider of medical equipment and laboratory instruments. The firm is principally engaged in selling scientific and medical equipment, service business, and medical equipment lease contracts. Its segments include Scientific equipment and medical equipment, and Service. Its products include endoscopy equipment, surgical equipment, aesthetic equipment, neonatal care equipment and laboratory equipment.
